Evidence map›Paper›PMID 41978679›Full record

ArticleF1000Research2026

Non‑pharmacological care for early-stage dementia through smart environments in Colombia: a mixed‑methods study and methodological guide for caregivers and patients.

Mariano Romero-Torres, Jon Arambarri, Tobias A Parodi-Camano

Abstract read
In one paragraph

Article in F1000Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mariano Romero-TorresCorporacion Unificada Nacional de Educacion Superior, Bogotá, Bogota, Colombia.
Jon ArambarriUniversidad Internacional Iberoamericana, Campeche, Campeche, Mexico.
Tobias A Parodi-CamanoCorporacion Unificada Nacional de Educacion Superior, Bogotá, Bogota, Colombia.ORCID https://orcid.org/0000-0003-4548-1058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dementia is increasing in Latin America, creating demand for non-pharmacological support that can be delivered safely at home. Smart environments and related digital tools may help caregivers and people with early-stage dementia by supporting safety, reminders, and communication. This study assessed needs and acceptability in Colombia and produced a methodological guide for technology selection. Methods: We conducted a sequential exploratory mixed-methods study. First, a focused evidence synthesis informed a feature catalogue and instrument design. Second, we administered a cross-sectional questionnaire to caregivers and people living with early-stage dementia. Quantitative data were summarised with descriptive statistics and non-parametric group comparisons; open-ended responses were analysed thematically and integrated with the quantitative findings. Results: Fifty-one responses were analysed. Safety-oriented functions (for example, fall detection and geolocation), reminders for activities of daily living, tele-assistance, and cognitive tele-stimulation were the most frequently prioritised. Acceptability was generally higher for low-burden technologies with clear usefulness, and age differences were limited across key comparisons. Conclusions: In this sample, smart-environment-enabled non-pharmacological support was feasible and broadly acceptable for early-stage dementia care. The methodological guide emphasises prioritising safety and reminders, reducing interaction burden, and incorporating privacy-by-design. Further studies should validate these findings with larger and more diverse samples and evaluate implementation outcomes.

Indexed as

CaregiversDementiaAgedColombiaCross-Sectional StudiesDigital HealthFemaleHumansMaleMiddle AgedSurveys and QuestionnairescaregiversColombiadementianon-pharmacological caresmart environments

Identifiers

PMID41978679
PMCPMC13070209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.